Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank57
3Y CAGR-21.1%
5Y CAGR-7.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-21.1%/yr
vs +12.8%/yr prior
5Y CAGR
-7.4%/yr
Recent deceleration
Acceleration
-34.0pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.45M | +5.3% |
| 2024 | $16.57M | -4.3% |
| 2023 | $17.31M | -51.3% |
| 2022 | $35.58M | +22.7% |
| 2021 | $29.00M | +13.0% |
| 2020 | $25.67M | +8.6% |
| 2019 | $23.63M | +7.6% |
| 2018 | $21.95M | +21.6% |
| 2017 | $18.05M | +155.6% |
| 2016 | $7.06M | - |